Can-Fite BioPharma Ltd.
CANF · AMEX
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,438 | -$2,438 | -$1,962 | -$1,962 |
| Dep. & Amort. | $12 | $12 | $3 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $126 | $126 | $85 | $85 |
| Change in WC | -$279 | -$279 | $268 | $268 |
| Other Non-Cash | $204 | $204 | -$194 | -$194 |
| Operating Cash Flow | -$2,376 | -$2,376 | -$1,801 | -$1,801 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$1 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $1,500 | $1,500 | -$1,500 | -$1,500 |
| Investing Cash Flow | $1,500 | $1,500 | -$1,501 | -$1,501 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,687 | $1,687 | $3,356 | $3,356 |
| Financing Cash Flow | $1,687 | $1,687 | $3,356 | $3,356 |
| Forex Effect | $5 | $5 | -$2 | -$2 |
| Net Chg. in Cash | $0 | $0 | $0 | -$4,719 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $0 | $0 | $0 |
| End Cash | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,377 | -$2,377 | -$1,801 | -$1,801 |